Maiden (NASDAQ:MHLD – Get Free Report) released its earnings results on Tuesday. The insurance provider reported ($0.16) earnings per share for the quarter, reports. The firm had revenue of $18.28 million during the quarter. Maiden had a negative return on equity of 16.55% and a negative net margin of 71.58%.
Maiden Stock Down 6.3 %
NASDAQ MHLD opened at $1.64 on Friday. The company has a 50 day moving average price of $1.68 and a two-hundred day moving average price of $1.88. The company has a current ratio of 0.86, a quick ratio of 0.75 and a debt-to-equity ratio of 1.22. Maiden has a 12-month low of $1.19 and a 12-month high of $2.55.
Hedge Funds Weigh In On Maiden
Institutional investors and hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC increased its holdings in Maiden by 98.4% in the 3rd quarter. SG Americas Securities LLC now owns 29,079 shares of the insurance provider’s stock valued at $51,000 after buying an additional 14,422 shares during the period. RPOA Advisors Inc. acquired a new position in Maiden during the 2nd quarter worth about $63,000. The Manufacturers Life Insurance Company acquired a new position in Maiden during the 3rd quarter worth about $66,000. BNP Paribas Financial Markets lifted its position in Maiden by 48.6% during the 1st quarter. BNP Paribas Financial Markets now owns 44,131 shares of the insurance provider’s stock valued at $99,000 after purchasing an additional 14,425 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its position in Maiden by 11.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 66,450 shares of the insurance provider’s stock valued at $150,000 after purchasing an additional 6,645 shares during the period. Institutional investors own 21.78% of the company’s stock.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on Maiden
About Maiden
Maiden Holdings, Ltd., through its subsidiaries, provides property and casualty insurance and reinsurance solutions to regional and specialty insurers in Europe, North America, and internationally. It operates in two segments, Diversified Reinsurance and AmTrust Reinsurance. The company writes treaties on a quota share basis and excess of loss basis.
Further Reading
- Five stocks we like better than Maiden
- The How And Why of Investing in Oil Stocks
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- What is the FTSE 100 index?
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
- 3 Healthcare Dividend Stocks to Buy
- Why Meta Should Rally All The Way Into 2025
Receive News & Ratings for Maiden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maiden and related companies with MarketBeat.com's FREE daily email newsletter.